CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,098 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 5,123 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 992 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,074 shares (to pay taxes)
- 4 Open-market buy Director bought 5,000 shares at $1.31 ($6,545)
- 4 Open-market buy Director bought 10,000 shares at an average $1.43 ($14,257)
- 4 Open-market buy Director bought 10,000 shares at $1.35 ($13,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes General Counsel, Secretary gave up 815 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,078 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,059 shares (to pay taxes)
- 4 Exercise or conversion Chief Scientific Officer acquired 5,000 shares (option exercise)
- 4 Exercise or conversion General Counsel, Secretary acquired 2,000 shares (option exercise)
Page 7 of 13 · 246 filings